¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, Á¦Ç°º°, ¸ðµåº°, ¾à¹°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens), By Product, By Mode, By Drug, By End-use, By Region, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1571602
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,194,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,571,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,325,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå ±Ô¸ð´Â 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.1% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 34¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±ÔÁ¤ Áؼö´Â ½ÃÀå ¼ºÀåÀÇ Áß¿äÇÑ ÃËÁøÁ¦ÀÔ´Ï´Ù. ¹Ì±¹ ±³ÅëºÎ(DOT)¿Í ¾à¹°³²¿ë ¹× Á¤½Åº¸°Ç°ü¸®±¹(SAMHSA)°ú °°Àº ¿¬¹æ ±ÔÁ¤Àº ÀÛ¾÷Àå ¾ÈÀüÀ» º¸ÀåÇϰí Ã¥ÀÓ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¾ÈÀüÀÌ Áß¿äÇÑ Á÷¹«¿¡ ´ëÇÑ °Ë»ç¸¦ Àǹ«È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¤Àº ƯÈ÷ ÁßÀåºñ ¹× ¿î¼Û°ú °ü·ÃµÈ »ê¾÷ Àü¹Ý¿¡ °ÉÃÄ °Ë»ç¸¦ Àǹ«È­Çϰí ÀÖ½À´Ï´Ù.

2020³â ¹Ì±¹ °øÁߺ¸°ÇÇùȸ´Â Á÷¾÷ ȯ°æ¿¡¼­ ¿ÀÇÇ¿ÀÀÌµå »ç¿ë Àå¾Ö(OUD)¿Í °ú´Ùº¹¿ë À§Çè¿¡ ´ëóÇϱâ À§ÇÑ Á¾ÇÕÀûÀÎ Àü·«À» Á¦½ÃÇÏ¸ç ¾à¹° °Ë»çÀÇ Á߿伺À» ´õ¿í °­Á¶Çß½À´Ï´Ù. ÀÌ Àü·«¿¡´Â ºÎ»ó ¿¹¹æ ÇÁ·Î±×·¥ °­È­, ÀÎü°øÇÐÀû À§Çè¿¡ ´ëÇÑ ´ëÀÀ, ¿ÀÇÇ¿ÀÀÌµå ¿À³²¿ë ±³À° ½Ç½Ã, µ¿·á Áö¿ø Á¦°ø, »êÀ纸ÇèÀ» ÅëÇÑ ¿ÀÇÇ¿ÀÀ̵å ó¹æ ±ÔÁ¦ µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Á¤Ã¥ÀÇ ÃßÁøÀ¸·Î Àû±ØÀûÀÎ ¾à¹° °Ë»ç ´ëÃ¥ÀÇ Çʿ伺ÀÌ ´õ¿í ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ±ÔÁ¦¿Í Á¤Ã¥Àû ¾Ð·Â¿¡ ´ëÀÀÇϱâ À§ÇØ ¹Ì±¹ ±³ÅëºÎ´Â 2023³â 5¿ù¿¡ »õ·Î¿î ±ÔÁ¤À» È®Á¤Çϰí ÃÖ¼Ò 2°³ÀÇ SAMHSA ÀÎÁõ °Ë»ç ±â°üÀÌ Âü¿©ÇÏ´Â Á¶°ÇÀ¸·Î ±³ÅëºÎ Àǹ« ¾à¹° °Ë»ç¿¡ ±¸°­¾× °Ë»ç¸¦ Çã¿ëÇϱâ·Î Çß½À´Ï´Ù. ÀÌ·¯ÇÑ ÁøÀüÀº ¾à¹° °Ë»çÀÇ ÁøÈ­¸¦ °­Á¶ÇÏ°í °Ë»ç ÇÁ·Î±×·¥ÀÇ À¯¿¬¼º°ú Á¤È®¼ºÀ» Çâ»ó½ÃŰ´Â °ÍÀÔ´Ï´Ù. °Ë»ç ¼±ÅÃÀÇ ÆøÀ» ³ÐÈûÀ¸·Î½á »õ·Î¿î ±ÔÁ¤Àº ±¸°­¾×ü °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí, °í¿ëÁÖ¿Í °Ë»ç Á¦°ø¾÷ü ¸ðµÎ¿¡°Ô ÀÌÀÍÀ» °¡Á®´ÙÁÖ¸ç, Àüü ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÒ °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

¶ÇÇÑ, ±Ù·ÎÀÚÀÇ ¾à¹° »ç¿ë Àå¾Ö(SUD)ÀÇ Áõ°¡´Â ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀåÀÇ ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àå¾ÖÀÇ È®»êÀº °á±Ù·ü Áõ°¡, »ý»ê¼º ÀúÇÏ, »ê¾÷ÀçÇØ Áõ°¡·Î À̾îÁý´Ï´Ù. ÀÌ¿¡ µû¶ó °í¿ëÁÖµéÀº ¾à¹°³²¿ë ¹®Á¦¸¦ ½Å¼ÓÇÏ°Ô ÆÄ¾ÇÇÏ°í ´ëóÇϱâ À§ÇØ ¾ö°ÝÇÑ ¾à¹° °Ë»ç ÇÁ·Î±×·¥À» ½ÃÇàÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀº ¾ÈÀüÇÏ°í »ý»êÀûÀÎ ÀÛ¾÷ ȯ°æÀ» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÉ »Ó¸¸ ¾Æ´Ï¶ó, Àå¾Ö°¡ ÀÖ´Â Á÷¿ø°ú °ü·ÃµÈ ¾÷¹«»ó À§Çè°ú ¹ýÀû Ã¥ÀÓÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, SUDÀÇ ºÎÁ¤ÀûÀÎ ¿µÇâ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó º¸´Ù Áøº¸µÇ°í Á¾ÇÕÀûÀÎ ¾à¹° °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Á¶Á÷ÀÌ º¸´Ù ¾ÈÀüÇÑ ÀÛ¾÷ ȯ°æÀ» Á¶¼ºÇÏ´Â °ÍÀ» ¿ì¼±½ÃÇÔ¿¡ µû¶ó ¾à¹° °Ë»ç´Â ¾ÈÀü ÇÁ·Î±×·¥ÀÇ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù. ÆÇ´Ü·Â ÀúÇÏ, »ç°íÀ² Áõ°¡ µî ¾à¹°³²¿ë°ú °ü·ÃµÈ À§Çè¿¡ ´ëÇÑ ÀνÄÀº °í¿ëÁÖµéÀÌ °­·ÂÇÑ Á¤Ã¥À» µµÀÔÇϵµ·Ï µ¿±â¸¦ ºÎ¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀº °Ç¼³, Á¦Á¶, ¿î¼Û µî À§Çèµµ°¡ ³ôÀº ¾÷Á¾¿¡¼­ ƯÈ÷ µÎµå·¯Áý´Ï´Ù. ¾à¹°³²¿ë ¹®Á¦¸¦ ½Äº°Çϰí ÇØ°áÇÔÀ¸·Î½á °í¿ëÁÖ´Â ÀáÀçÀû À§ÇèÀ» ÁÙÀ̰í, ÀÛ¾÷Àå ÀüüÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۸ç, °ü·Ã ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÈÀü¿¡ ´ëÇÑ Àνİú ³ë·ÂÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¾ÇÕÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå : ¸ðµå ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå : ¾à¹° ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦8Àå ¹Ì±¹ÀÇ °í¿ëÁÖ ¹× Á÷Àå ¾à¹° °Ë»ç ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦9Àå °æÀï »óȲ

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Employer And Workplace Drug Testing Market Growth & Trends:

The U.S. employer and workplace drug testing market size is anticipated to reach USD 3.47 billion by 2030, growing at a CAGR 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Regulatory compliance is a significant driver for market growth. Federal regulations, such as those from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), mandate testing for safety-sensitive roles to ensure workplace safety and mitigate liability risks. These regulations enforce testing across industries, especially those involving heavy machinery or transportation.

In 2020, the American Public Health Association further emphasized the importance of drug testing by advocating for comprehensive strategies to address Opioid Use Disorder (OUD) and overdose risks in occupational settings. Their recommendations included strengthening injury prevention programs, addressing ergonomic risks, providing opioid misuse education, offering peer support, and regulating opioid prescriptions through workers' compensation. This policy push underscores the growing need for proactive drug testing measures.

In response to these regulatory and policy pressures, the U.S. DOT finalized new regulations in May 2023, allowing oral fluid testing for DOT-mandated drug tests, provided that at least two SAMHSA-certified laboratories are involved. This development highlights the evolving landscape of drug testing, enhancing the flexibility and accuracy of testing programs. By broadening testing options, the new regulation is expected to drive demand for oral fluid testing solutions, benefiting both employers and testing providers and supporting the overall market growth.

Additionally, the increase in substance use disorders (SUDs) among the workforce significantly impacts the growth of the U.S. employer & workplace drug testing market. The prevalence of these disorders contributes to higher rates of absenteeism, lower productivity, and increased workplace accidents. Employers are therefore compelled to implement rigorous drug testing programs to identify and address substance abuse issues promptly. This proactive approach not only helps in maintaining a safe and productive work environment but also reduces operational risks and legal liabilities associated with impaired employees. The growing recognition of the adverse effects of SUDs drives demand for more advanced and comprehensive drug testing solutions, contributing to the market's expansion.

Furthermore, as organizations prioritize creating safer work environments, drug testing becomes an essential component of their safety programs. The awareness of the risks associated with substance abuse, including impaired judgment and increased accident rates, motivates employers to implement robust policies. This focus on safety is particularly pronounced in high-risk industries such as construction, manufacturing, and transportation. By identifying and addressing substance abuse issues, employers can mitigate potential hazards, improve overall workplace safety, and reduce associated costs. The increased awareness and commitment to safety drive the demand for comprehensive solutions, fueling market growth.

U.S. Employer And Workplace Drug Testing Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

Chapter 9. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â